Vitolo, U <br/><br/>
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.  [electronic resource] 

 -  Leukemia  Feb 2002 
 - 268-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2402349  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bleomycin--administration & dosage<br/>Carmustine--administration & dosage<br/>Chromosomes, Human, Pair 3--genetics<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>DNA Mutational Analysis<br/>DNA, Neoplasm--genetics<br/>DNA-Binding Proteins--genetics<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Genes, bcl-2<br/>Humans<br/>Life Tables<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Melphalan--administration & dosage<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Neoplasm Staging<br/>Point Mutation<br/>Prednisolone--administration & dosage<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-bcl-6<br/>Proto-Oncogenes<br/>Transcription Factors--genetics<br/>Treatment Outcome<br/>Vincristine--administration & dosage